MedTrace Logo

International Multi Centre Randomized Clinical Trial Of Anticoagulation In Children Following Fontan Procedures

NCT00182104 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 111

Last updated 2007-04-20

No results posted yet for this study

Summary

Compare heparin/warfarin to ASA for thromboembolic prophylaxis in the first two years following Fontan procedures.

Conditions

  • Heart Defect
  • Triscupid Atresia

Interventions

DRUG

Warfarin vs ASA

Sponsors & Collaborators

  • Heart and Stroke Foundation of Canada

    collaborator OTHER

  • Hamilton Health Sciences Corporation

    lead OTHER

Principal Investigators

  • Paul Monagle, MD · Royal Children's Hospital, Parkville, Victoria, Australia

  • Brian McCrindle, MD · The Hospital for Sick Children

  • Robin Roberts, MD · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-08-31
Completion
2005-07-31

Countries

  • Australia
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00182104 on ClinicalTrials.gov